Protalix BioTherapeutics
PLX
#8318
Rank
โ‚น21.13 B
Marketcap
โ‚น262.76
Share price
0.34%
Change (1 day)
12.68%
Change (1 year)

EPS for Protalix BioTherapeutics (PLX)

EPS in 2025 (TTM): โ‚น1.74

According to Protalix BioTherapeutics 's latest financial reports the company's current EPS (TTM) is โ‚น1.81. In 2024 the company made an earnings per share (EPS) of โ‚น3.61 a decrease over its 2023 EPS that were of โ‚น10.84.

EPS history for Protalix BioTherapeutics from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น1.74-51.69%
2024โ‚น3.61-66.67%
2023โ‚น10.84-138.71%
2022-โ‚น27.99-50%
2021-โ‚น55.98181.82%
2020-โ‚น19.86-82.11%
2019-โ‚น111.06-31.67%
2018-โ‚น162.53-72.31%
2017-โ‚น586.91124.14%
2016-โ‚น261.85-147.54%
2015โ‚น550.79-290.63%
2014-โ‚น288.946.67%
2013-โ‚น270.88130.77%
2012-โ‚น117.38-69.77%
2011-โ‚น388.2619.44%
2010-โ‚น325.06-12.2%
2009-โ‚น370.2136.67%
2008-โ‚น270.88-37.5%
2007-โ‚น433.4150%
2006-โ‚น288.943.23%
2005-โ‚น279.91138.46%
2004-โ‚น117.38-74%
2003-โ‚น451.47-0%
2002-โ‚น451.47-50%
2001-โ‚น902.94233.33%
2000-โ‚น270.88-84.21%
1999-โ‚น1,716-24%
1998-โ‚น2,257-600%
1997โ‚น451.47-16.67%
1996โ‚น541.76

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
โ‚น155.31 8,500.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚น389.17 21,450.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
-โ‚น9.93-650.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น56.89 3,050.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel